We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

11 hedge funds and large institutions have $6.71M invested in BELLUS Health Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

90% less funds holding

Funds holding: 10611 (-95)

97% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 98

99% less capital invested

Capital invested by funds: $828M → $6.71M (-$822M)

100% less funds holding in top 10

Funds holding in top 10: 70 (-7)

Holders
11
Holders Change
-95
Holders Change %
-89.62%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
1
Reduced
4
Closed
98
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
+$525K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
101
Deutsche Bank
Germany
-$39K -5,416 Closed
Group One Trading
102
Group One Trading
Illinois
-$35.8K -4,975 Closed
FDCDDQ
103
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$20.5K -2,894 Closed
Osaic Holdings
104
Osaic Holdings
Arizona
-$17.3K -2,400 Closed
LFG
105
Larson Financial Group
Missouri
-$8.21K -1,140 Closed
TWC
106
TD Waterhouse Canada
Ontario, Canada
-$9.83K -1,065 Closed
Daiwa Securities Group
107
Daiwa Securities Group
Japan
-$4K -506 Closed
GCM
108
Gables Capital Management
Florida
-$965 -134 Closed
TWA
109
TCI Wealth Advisors
Arizona
-$720 -100 Closed

BLU Hedge Fund Activity: Q2 2023 in Review

11 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q2 2023, worth a combined $6.71M — down 99% from $828M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of BLU and 3 opened new positions — a net loss of 95 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Carmignac Gestion, opening a new position worth an estimated $2.93M. The largest seller was RA Capital Management, exiting entirely with an estimated $91M sold.

  • 11 institutional investors held BELLUS Health Inc. (BLU) as of Q2 2023, down from 106 in Q1 2023.
  • Funds reported $6.71M of BELLUS Health Inc. stock for Q2 2023, down 99% quarter-over-quarter.
  • 3 funds opened new BELLUS Health Inc. positions in Q2 2023 and 98 closed out, a net change of -95 holders.
  • The largest BELLUS Health Inc. buyer in Q2 2023 was Carmignac Gestion, an estimated $2.93M added.
  • The largest BELLUS Health Inc. seller in Q2 2023 was RA Capital Management, an estimated $91M sold.

Based on aggregated 13F filings for Q2 2023.